Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors.
about
Hepatic arterial embolization in patients with neuroendocrine tumorsTreatment of liver metastases in patients with neuroendocrine tumors of gastroesophageal and pancreatic originArterial Therapies of Non-Colorectal Liver MetastasesGastrointestinal neuroendocrine tumors: pancreatic endocrine tumorsManagement and outcomes of patients with recurrent neuroendocrine liver metastasis after curative surgery: An international multi-institutional analysis.Hepatic artery embolization for neuroendocrine tumors: postprocedural management and complicationsClinicopathological characteristics and prognosis-related factors of resectable pancreatic neuroendocrine tumors: a retrospective study of 104 cases in a single Chinese center.Multimodal management of neuroendocrine liver metastases.Treatment of liver metastases in patients with neuroendocrine tumors: a comprehensive review.Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)A multimodal approach to the management of neuroendocrine tumour liver metastasesHepatic neuroendocrine metastases: chemo- or bland embolization?Emerging approaches in the management of patients with neuroendocrine liver metastasis: role of liver-directed and systemic therapies.Intra-arterial liver-directed therapies for neuroendocrine hepatic metastases.Safety and efficacy of doxorubicin-eluting superabsorbent polymer microspheres for the treatment of liver metastases from neuroendocrine tumours: preliminary results.Liver abscess as a complication of hepatic transarterial chemoembolization: a case report, literature review, and clinical recommendations.Hepatic arterial chemoembolization using drug-eluting beads in gastrointestinal neuroendocrine tumor metastatic to the liver.Surgical treatment of liver metastases in neuroendocrine neoplasms.Liver-directed therapies in liver metastases from neuroendocrine tumors of the gastrointestinal tract.Surgical management of noncolorectal cancer liver metastases.Role of surgery and transplantation in the treatment of hepatic metastases from neuroendocrine tumor.Decision Making for Selection of Transarterial Locoregional Therapy of Metastatic Neuroendocrine Tumors.Recent progress in the understanding, diagnosis, and treatment of gastroenteropancreatic neuroendocrine tumors.Embolotherapy for Neuroendocrine Tumor Liver Metastases: Prognostic Factors for Hepatic Progression-Free Survival and Overall Survival.Hepatic arterial embolization for the treatment of metastatic neuroendocrine tumors.Hepatic artery embolization in advanced neuroendocrine tumors: Efficacy and long-term outcomes.Elevated Alkaline Phosphatase Prior to Transarterial Chemoembolization for Neuroendocrine Tumors Predicts Worse Outcomes.Treatment of neuroendocrine tumor liver metastases."Cherry picking", a multiple non-anatomic liver resection technique, as a promising option for diffuse liver metastases in patients with neuroendocrine tumours.Liver transarterial embolizations in metastatic neuroendocrine tumors.Surgery versus intra-arterial therapy for neuroendocrine liver metastasis: a multicenter international analysis.Long term survival analysis of hepatectomy for neuroendocrine tumour liver metastases.
P2860
Q21198838-544A8A8A-0ECA-42D0-9640-DEE791B6AF13Q21296729-BAD05087-FE53-44EE-A752-4B69B7D590D8Q26764990-A88B356A-4F05-42E8-A331-229BB7688AF6Q28290833-C363715D-18D3-46AE-92BD-30B9712F0866Q30252389-D25085E9-6FFA-4E3F-86FA-67908A84A742Q34268850-9720CFD2-B246-4E6F-A714-61FFABA95AD3Q34387994-640F8774-A6E4-443F-AC0A-7E5B316AB606Q34528199-46E712B9-388C-41F5-B585-AF5E4698D475Q35371197-050D5969-5D45-4BA9-A61E-2FD7A8946D36Q35760798-DCC0F4F7-85B5-465D-98C5-4A39147DFDBBQ35810562-A5751014-4AF5-46DE-AFBC-8052D96A5C5AQ35930191-F5E7F9B2-D287-40FA-8328-EDED910B568BQ36512778-A7B5717F-C0DB-4205-9D18-736CC8D146F7Q36980633-EF1CA4DB-AA5F-4F3C-8EA0-F3A872FC1EC7Q37671474-3D6DBBE2-6F8B-45DE-B3DC-47CFD433D3F6Q37820116-DC4D8F99-5AA0-4041-88E4-A7EB3DA3235FQ37856906-F0B5F114-0BB7-4F2F-89A3-1E8A52865214Q37982721-C3EF817E-2A63-4477-8752-D5A8E4BC1BD0Q38019461-9835CC8E-6601-488C-899B-9662ACD39953Q38224364-CBDE17D4-F01D-48FA-B197-39D4DE65B954Q38262113-579A4973-4860-4870-AC33-9650795D53B9Q39349632-25508D8A-0191-4C85-9285-2EC023C9E13FQ39773838-351AE0E1-F077-49C4-891B-148CCC2C9FD7Q40542715-A2294334-E4F9-4AC2-A881-003D85A039B0Q40869761-E97A64F5-20B4-44DF-8BA3-803C1B57BBF4Q41053501-9B95639A-4A10-4509-B489-382BBF256539Q41196104-D7BB90A8-8920-4FCB-A5CC-E4D4580BEC63Q42287138-45F1543B-E5F2-43CF-86DD-29AB68990BE3Q43475328-656302FA-7B4B-46E0-87C5-C29A5D528B3DQ47869784-41A8B946-4626-45C2-85F3-59788C956B34Q53151516-8D3BB348-FCB3-4BDF-B0EE-5D495519C0A8Q55411511-88FA42D3-EAEE-4323-8432-35B271BD6D25
P2860
Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Long-term outcome after chemoe ...... ns from neuroendocrine tumors.
@en
Long-term outcome after chemoe ...... ns from neuroendocrine tumors.
@nl
type
label
Long-term outcome after chemoe ...... ns from neuroendocrine tumors.
@en
Long-term outcome after chemoe ...... ns from neuroendocrine tumors.
@nl
prefLabel
Long-term outcome after chemoe ...... ns from neuroendocrine tumors.
@en
Long-term outcome after chemoe ...... ns from neuroendocrine tumors.
@nl
P2093
P356
P1476
Long-term outcome after chemoe ...... ns from neuroendocrine tumors.
@en
P2093
Alexander S Ho
Benjamin Tan
Daniel B Brown
Jennifer E Gould
Joel Picus
Michael D Darcy
Thomas K Pilgram
P304
P356
10.2214/AJR.06.0933
P407
P577
2007-05-01T00:00:00Z